The Global Challenge Impact Fund invests in businesses that combine significant return on investment with significant social, environmental, and governance impacts. That is, the Challenge Impact Fund invests in breakthrough technologies and companies that represent balanced ROI/ESG opportunities to create scalable, sustainable solutions for abundant food, health, and prosperity.
The Fund is aligned programmatically with the mission and values of Global Action Platform, the leading university-business alliance advancing food, health, and prosperity solutions. Since the launch of the new Sustainable Development Goals in September 2015, the Challenge Fund is also aligned with SDG1-3.
The Challenge Fund makes investments through a global competition managed by Global Action Platform. The competition is open to innovators, researchers, entrepreneurs, and companies from around the world that present investible opportunities in the areas of the Challenge focus. To date, the Nashville Entrepreneur Center has provided outside review and initial ranking of submitted proposals; final decisions on investment are made by the investors.
Finalists in the Challenge Fund competition are invited to the annual Global Action Summit—Nashville; and the recipient(s) of investments are introduced and recognized at the Global Abundance Dinner, hosted by Fareed Zakaria (CNN) on the final night of the Summit.
Early Stage Global Action Challenge offers early stage investment opportunities up to $100K for innovations and early business development for enterprises that can have a transformative impact on food, health, and prosperity. The competitive submission is open to researchers, entrepreneurs, and innovators from around the world. Finalists will be recognized at the Global Action Summit and investment decisions will be announced at the closing dinner of the Summit, moderated by Fareed Zakaria, CNN.
Applications for Early Stage funding is open to submission throughout the year. Investment decisions are determined and announced quarterly.
Because of a growing pool of challenge impact funds and international interest in our Global Action Challenge, new guidelines and procedures are currently under review and development for our investments of $1M and greater. We are not currently accepting new applications for the $1Million Investment Challenge Fund.
New submission procedures and timelines will be announced here.
The $1 Million Investment Award, presented to US Biologic at the 2013 Summit was recently increased in 2014 to become a $1.5 Million investment. The innovation developed by US Biologic prevents the transmission cycle of Lyme disease. Lyme disease is the #1 vector-borne disease in the U.S. with over 300,000 new cases each year.